Mergers & Acquisitions

Acquisition of public minority stake in Micro Therapeutics, Inc. completed

Published in Blood Weekly, February 9th, 2006

Ev3 Inc. (EVVV), an endovascular device company, announced the successful completion of its acquisition of the outstanding shares of Micro Therapeutics, Inc. (MTI) that it did not already own through the merger of a wholly owned subsidiary of ev3 with and into MTI.

MTI, an endovascular medical device company focused on neurovascular disease and disorders, will continue operations as a wholly owned subsidiary of ev3.

As a result of the acquisition, MTI stockholders will receive 0.476289 of a share of ev3 common stock for each share of MTI common stock that they own. Ev3 will issue approximately 7.0 million new shares of its common stock to MTI's...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2006-02-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry